Concourse Financial Group Securities, Inc. Journey Medical Corp Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding DERM
# of Institutions
39Shares Held
2.93MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.2 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.2 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.16 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$992,3400.0% of portfolio
-
American Financial Group Inc180KShares$666,0000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $42.9M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...